Menu

PROGRAM - Subject to Change
> San Diego Heart Failure 2024 Brochure (PDF)
Friday, July 19, 2020
Pacific Time

7:30am

Registration/Coffee/Visit Exhibits

8:00am

Breakfast Served

8:00-9:00

PRODUCT THEATRE I - Non-CME
Breaking the Cycle of Recurrent Pericarditis: A Targeted Approach for Pain Relief, Inflammation Resolution, and Flare Prevention
Speaker: Rigved Tadwalkar, MD
Supported by: Kiniksa Pharmaceuticals

9:10-9:15

Welcome and Introduction to the Symposium: Heart Failure in 2023
Barry Greenberg, MD, FACC

SESSION I - Modifying Lifestyle and Treating Risk Factors to Prevent CV Disease
Pam Taub, MD, FACC (Moderator)

9:15-9:35

FEATURED LECTURE I
The Cardiometabolic Syndrome: A New Framework for Understanding Heart Failure

Pam Taub, MD, FACC

9:35-9:50

Treating Hypertension: Goals and New Strategies for Achieving Them
Joachim Ix, MD

9:50-10:05

The Role of GLP1 Agonists in Cardiovascular Disease and Heart Failure
Yehuda Handelsman, MD

10:05-10:20

New Options for Treating Dyslipidemia
Harpreet Bhatia, MD, FACC

10:20-10:30

Risk Management: A Patient’s Perspective
Rhonda Monroe

10:30-10:50

Panel Discussion on Managing Cardiometabolic Risk
Pam Taub, MD, FACC (Moderator)
Drs. Handelsman, Ix, Bhatia and Jade Kozuch, PharmD, and Rhonda Monroe - Patient Advocate (Panelists)

10:50-11:20

Coffee Break/Visit Exhibits

Session II - Advances in Patient Management
Barry Greenberg, MD, FACC (Moderator)

11:20-11:40

FEATURED LECTURE II
Advances in Understanding and Treating Patients with HFpEF

Uri Elkayam, MD, FACC

11:40-11:55

Using Artificial Intelligence and Machine Learning To Diagnose and Predict Outcomes in Heart Failure – What Does the Future Hold?
David Krummen, MD, FACC

11:55-12:10pm

Pulmonary Arterial Hypertension (PAH)
Jenny Yang, MD

12:10-12:25

Advances in Remote Monitoring
Hao (Howie) Tran, MD, FACC

12:25-12:40

Panel Discussion/Q & A
Barry Greenberg, MD, FACC (Moderator)
Drs. Elkayam, Krummen, Yang, Tran (Discussants)

12:50-1:50

PRODUCT THEATRE II - Lunch Session - Non-CME
Symptomatic Obstructive Hypertrophic Cardiomyopathy: A review of the phase 3 data and ongoing long-term extension trials with the first and only approved cardiac myosin inhibitor for adults with oHCM
Speaker: TBD
Supported by: Bristol Myers Squibb

1:50-2:10

Visit Exhibits

Session III - Cardiomyopathy: Understanding Causes and Novel Therapies
Marcus Anthony (Tony) Urey, MD (Moderator)

2:10-2:30

FEATURED LECTURE III
Diagnosing and Treating Amyloidosis

Marcus Anthony (Tony) Urey, MD

2:30-2:45

Hypertrophic Cardiomyopathy
Jorge Silva, MD

2:45-3:00

Genetic Testing: When To Order It and What To Do With the Results
Kimberly Hong, MD

3:00-3:20

FEATURED LECTURE IV
Genetic Causes of Cardiomyopathy

Eric Adler, MD, FACC

3:20-3:35

Gene Therapy for Cardiac Disease
Barry Greenberg, MD, FACC

3:35-3:50

Recognizing and Treating Uncommon Causes of Cardiomyopathy
Ben Cruz, MD

3:50-4:05

A Patient’s Perspective
Lisa Salberg, Patient Advocate
Founder and CEO Hypertrophic Cardiomyopathy Association

4:05-4:40

Case Presentation / Q & A
Marcus Anthony (Tony) Urey (Presenter)
Drs. Silva, Hong, Adler, Greenberg, Cruz, Lisa Salberg - Patient Advocate (Panelists)

4:40

Adjourn for the Day


Saturday, July 20

7:30-8:00am

Registration Open

8:00-9:00

PRODUCT THEATRE III - Non-CME
Breakfast Session
Harnessing SGLT Inhibition in the Treatment and Prevention of HF
Speakers: Barry Greenberg, MD and Matthew Budoff, MD
Supported by: Lexicon

9:15-9:40

Founders Lecture: The Future of Heart Failure Care
Barry Greenberg, MD, FACC

Session IV - Management of Patients with Heart Failure with Reduced Ejection Fraction
Barry Greenberg, MD, FACC (Moderator)

9:40-9:55

SGLT2 Inhibitors: A Therapy for All Patients With Heart Failure?
Clyde Yancy, MD

9:55-10:15

Guideline Directed Medical Therapy for Patients with HFrEF
Gregg Fonarow, MD, FACC

10:15-10:30

Providing Care for All
Luis Castellanos, MD

10:30-10:45

Diagnosing and Treating Iron Deficiency in Patients with Heart Failure
Hilary Shapiro, MD, FACC

10:45-11:00

Other Therapies (Finerenone, Hydralazine/Isosorbide, Ivabradine, Fish Oil)
Quan Bui, MD

11:00-11:10

Living with Heart Failure: What Do Patients Want? – A Patient’s Perspective
Rhonda Monroe

11:10-11:30

Panel Discussion - Q & A
Barry Greenberg, MD, FACC (Moderator)
Drs. Fonarow, Yancy, Castellanos, Shapiro, Bui and Trina Huynh Pharm D, Julia McCain PA, Rhonda Monroe (Panelists)

11:30-11:45

Visit Exhibits

11:45-12:45

PRODUCT THEATRE IV - Lunch Session - Non-CME
A Treatment Option for Patients with Heart Failure
Speakers: Vladimir Yurukov, PharmD, BCPS, APh and Paul Tomasic, MD, MS, FACP, FACE
Supported by: AstraZeneca

12:45-1:00

Visit Exhibits

1:00-1:25

10th Annual Stanley Lloyd, MD Lecture
Heart Failure and Pregnancy
Uri Elkayam, MD, FACC

Special Session: Advances in Treating Patients with Cardiogenic Shock
Hao (Howie) Tran, MD, FACC (Moderator)

1:25-1:40

Cardiogenic Shock: Importance of Early Recognition
Kimberly Hong, MD

1:40-1:55

Virtues of a Cardogenic Shock Program
Chris Barnett, MD, FACC

1:55-2:10

Management of Cardiogenic Shock
Hao (Howie) Tran, MD, FACC

2:10-2:25

Recognizing CAD in Patients with Heart Failure
Greg Fonarow, MD, FACC

2:25-2:40

Impact of Revascularization on HF Symptoms: Insights from Restore-EF and Protect III
Chris Barnett, MD, FACC

2:40-3:00

Coffee Break/Visit Exhibits

Session V - Novel and Advanced Therapies for Heart Failure
Barry Greenberg, MD, FACC (Moderator)

3:00-3:20

FEATURED LECTURE V
Heart Pumps Now and For the Future

Mandeep Mehra, MD

3:20-3:40

FEATURED LECTURE VI
Advances in Heart Transplantation - What Does the Future Hold?

Victor Pretorius, MD

3:40-4:00

Novel Interventions for Treating the Failing Heart
Ryan Reeves, MD

4:00-4:20

Panel Discussion / Q & A
Barry Greenberg, MD, FACC (Moderator)
Drs Mehra, Pretorius and Reeves (Panelists)

4:20

Adjourn Until 31st Annual San Diego Heart Failure Symposium in July 2025